EW vs SCL · P/E 47, rev $1.39B vs P/E 22, rev $2.18B
Edwards Lifesciences Corp (EW) versus Stepan Company (SCL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Not investment advice. Open the EW and SCL stock pages for the full models.
Not investment advice.